Who invested in Particella?

Investors on record for Particella: IndieBio.

Particella

Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company that has developed an oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.

Health and bioIndieBio

Website: particella.bio.

Category: Health and bio.

Domain age: 3 years.

On Recent Funding since: Oct 11, 2026.

About Particella

Recent Funding lists Particella under Health and bio. It went through IndieBio (IndieBio SF 05).

Funding rounds

April 14, 2023
Website created
IndieBio SF 05
IIndieBio · batch
Source: indiebio.co

Investors

IIndieBioaccelerator

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026

Questions and sources

Particella: questions and answers

Who invested in Particella?: Investors on record for Particella: IndieBio.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/particella (get a free API key).